Military Blood Supply Insufficient for Large-Scale Combat Operations

Battlefield Blood Supply: A Looming Challenge for Trauma Care

Hemorrhage remains the leading cause of preventable death in trauma, a reality familiar to clinicians in both civilian and military medicine [1, 2, 3]. The use of whole blood for resuscitation in acute traumatic hemorrhage has demonstrated improved patient outcomes [3, 4, 5]. However, the logistical challenge of maintaining an adequate blood supply, particularly in austere or contested environments, can severely constrain efforts to provide effective trauma care [6]. As the nature of military conflict evolves, it is critical for physicians involved in trauma support to understand the precise limitations of current blood supply strategies to prepare for future operational demands.

The Shifting Landscape of Combat Trauma Resuscitation

A new analysis highlights a critical vulnerability in military trauma care, confirming that hemorrhage remains the leading cause of preventable battlefield mortality. While early whole blood resuscitation proved effective during the Global War on Terror, those successes were enabled by relatively secure operational conditions that allowed for consistent resupply. The researchers caution that future large-scale combat operations (LSCO) are unlikely to afford such logistical certainty, posing a direct threat to patient survival. This anticipated shift in the operational environment means that projected casualty volumes could quickly overwhelm Role 2 Forward Resuscitative Surgical Detachments (FRSDs), which are the mobile surgical teams tasked with providing advanced trauma care near the front lines. The study also questions the capacity of walking blood banks (WBB), or pre-screened donors available on-site, to fill the gap. Consequently, the authors sought to quantify the resilience of the current blood supply chain for an FRSD and measure the specific benefit provided by WBB augmentation under the high-stress conditions of an LSCO.

Modeling Battlefield Blood Logistics

To quantify the breaking points of the battlefield blood supply, the researchers constructed a sophisticated computer simulation. They developed a discrete-time, daily-step simulation model, which is a program that calculates blood supply and demand in 24-hour increments to mimic real-world conditions over a 30-day conflict. The model was designed to track whole blood dynamics for a Role 2 Forward Resuscitative Surgical Detachment (FRSD). A key feature was its use of an age-segmented inventory, a method that tracks the age of each blood unit to account for expiration, a critical real-world constraint. The simulation's baseline scenario started with a standard stock of 120 units of whole blood, replenished with another 120 units every 3 days. To this, the model added a 100-donor walking blood bank (WBB), realistically factoring in a 56-day post-donation deferral period. Daily casualties were generated stochastically, or with controlled randomness, to reflect the unpredictable surges of combat. Demand was calculated assuming 20% of casualties require transfusion at a rate of 8 units per patient. The primary outcomes were days-to-failure, defined as the first day a needed unit of blood was unavailable, and the total percentage of demand met over the 30-day period.

Conventional Supply: Rapid Failure Under High Demand

The simulation's projections of blood demand proved to be highly accurate, lending significant weight to its findings. The model's calculated mean 30-day demand of 10,075.2 units was nearly identical to the expected demand of 10,080 units used in official LSCO planning estimates. This validation of the model's accuracy makes its subsequent findings on supply failure particularly concerning for medical planners. The results show that the conventional supply chain, without any augmentation, is exceptionally fragile under high-intensity conditions. The standard resupply strategy failed rapidly once the average number of casualties exceeded 30 per day. In these scenarios, the median time to failure was just 2 days (interquartile range [IQR], 1-5 days). This indicates that in half of the simulations, the FRSD ran out of blood within 48 hours of the conflict reaching this intensity, a stark finding for clinicians who may be tasked with managing mass casualty events.

Limited Buffer from Walking Blood Banks

The study then evaluated whether a walking blood bank (WBB) could sufficiently buffer the fragile conventional supply chain. With a WBB, the system's durability improved at lower casualty rates; at an average of 30 casualties per day, the median days-to-failure extended to 11 days (IQR, 7-22). However, this benefit eroded quickly as the operational tempo increased. At 40 casualties per day, the median time to failure with WBB support plummeted to 5 days (IQR, 2-7). At 50 casualties per day, the system's integrity was nearly gone, with a median time to failure of only 2 days (IQR, 2-4). Beyond this rate, the model showed near-immediate failure even with the WBB. Overall, the percentage of total blood demand that could be met declined sharply as casualty rates rose. The authors found that demand fulfillment was only modestly improved by WBB support, demonstrating that while a WBB can provide a temporary surge capacity, it is not a substitute for a robust, high-volume supply chain.

Implications for Future Battlefield Medical Support

The study's conclusions present a stark warning for military medical planners and forward-deployed clinicians: current blood supply strategies for Forward Resuscitative Surgical Detachments (FRSDs) are not sustainable under projected large-scale combat operations (LSCO) casualty conditions. The simulation demonstrates that a standard supply chain can fail in as little as 2 days when daily casualties exceed 30. While augmenting this with a 100-donor walking blood bank (WBB) provides a limited buffer, this benefit evaporates as casualty rates climb, with the system still failing in 2 days at a rate of 50 casualties per day. The critical takeaway is that WBBs cannot replace the need for scalable, reliable resupply and forward sustainment in a contested environment. For physicians preparing to provide care in future conflicts, these findings underscore an urgent need for systemic solutions beyond on-site donors. Without new logistical capabilities for storing and transporting blood products at scale, clinicians on the front lines will face critical shortages that directly impact their ability to prevent deaths from hemorrhage.

References

1. Horst RAVD, Rijnhout TWH, Noorman F, et al. Whole blood transfusion in the treatment of acute hemorrhage, a systematic review and meta-analysis.. The journal of trauma and acute care surgery. 2023. doi:10.1097/TA.0000000000004000

2. Risha M, Alotaibi AM, Smith SA, et al. Does early transfusion of cold-stored whole blood reduce the need for component therapy in civilian trauma patients? A systematic review. Journal of Trauma and Acute Care Surgery. 2024. doi:10.1097/TA.0000000000004429

3. Ibrahim W, Monge KM, Menzel J, et al. Whole-Blood vs Component Therapy in Adult Trauma: An Updated Systematic Review and Meta-Analysis.. JAMA surgery. 2026. doi:10.1001/jamasurg.2026.0197

4. Shackelford SA, Gurney JM, Taylor AL, et al. Joint Trauma System, Defense Committee on Trauma, and Armed Services Blood Program consensus statement on whole blood.. Transfusion. 2021. doi:10.1111/trf.16454

5. Malkin M, Nevo A, Brundage S, Schreiber M. Effectiveness and safety of whole blood compared to balanced blood components in resuscitation of hemorrhaging trauma patients - A systematic review.. Injury. 2020. doi:10.1016/j.injury.2020.10.095

6. García AF, Caicedo Y, Gempeler A, et al. Transfusion of modified whole blood versus blood components therapy in patients with severe trauma: Randomized controlled trial protocol (WEBSTER trial).. Injury. 2025. doi:10.1016/j.injury.2025.112173